British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.
Price, Elizabeth J Benjamin, Stuart Bombardieri, Michele Bowman, Simon Carty, Sara Ciurtin, Coziana Crampton, Bridget Dawson, Annabel Fisher, Benjamin A Giles, Ian
Price, Elizabeth J
Benjamin, Stuart
Bombardieri, Michele
Bowman, Simon
Carty, Sara
Ciurtin, Coziana
Crampton, Bridget
Dawson, Annabel
Fisher, Benjamin A
Giles, Ian
Abstract
Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.
MIDER Authors
Affiliations
Date
2025-02-01
Type
Practice Guideline
Collections
Citation
Price EJ, Benjamin S, Bombardieri M, Bowman S, Carty S, Ciurtin C, Crampton B, Dawson A, Fisher BA, Giles I, Glennon P, Gupta M, Hackett KL, Larkin G, Ng WF, Ramanan AV, Rassam S, Rauz S, Smith G, Sutcliffe N, Tappuni A, Walsh SB. British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease. Rheumatology (Oxford). 2025 Feb 1;64(2):409-439